Published in Clin Diagn Virol on February 01, 1996
Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients. J Virol (2003) 1.38
Avian endogenous retrovirus EAV-HP shares regions of identity with avian leukosis virus subgroup J and the avian retrotransposon ART-CH. J Virol (2000) 1.17
Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA. J Virol (1997) 1.11
Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. PLoS One (2012) 1.08
Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerg Infect Dis (2001) 1.00
Characterization of endogenous avian leukosis viruses in chicken embryonic fibroblast substrates used in production of measles and mumps vaccines. J Virol (2001) 0.94
No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures. J Clin Microbiol (2001) 0.88
Intact EAV-HP endogenous retrovirus in Sonnerat's jungle fowl. J Virol (2001) 0.85
Detection of an RNA-dependent DNA polymerase activity. Clin Diagn Virol (1996) 0.79
Mortality in workers in poultry slaughtering/processing plants: the Missouri poultry cohort study. Occup Environ Med (2003) 0.78
Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis. Vaccine (2016) 0.75
Detection of avian retroviruses in vaccines by amplification on DF-1 cells with immunostaining and fluorescent product-enhanced reverse transcriptase endpoint methods. J Clin Microbiol (2013) 0.75
Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara. Microorganisms (2013) 0.75
Matrix and backstage: cellular substrates for viral vaccines. Viruses (2014) 0.75
Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNAase I. Cell (1980) 12.78
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30
Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science (1984) 5.43
Hb switching in chickens. Cell (1980) 4.88
Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet (1984) 3.77
Perilunate dislocations and fracture-dislocations: a multicenter study. J Hand Surg Am (1993) 3.75
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med (1985) 2.20
Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci U S A (1994) 1.84
A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell (1997) 1.80
Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr (2000) 1.69
Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis (1999) 1.58
Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS (1997) 1.50
Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis (2000) 1.41
False-positive HIV-1 virus cultures using whole blood. AIDS (1992) 1.40
Antibodies against three purified proteins of the human type C retrovirus, human T-cell leukemia-lymphoma virus, in adult T-cell leukemia-lymphoma patients and healthy Blacks from the Caribbean. Cancer Res (1983) 1.30
Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein. Science (1984) 1.21
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA. J Virol (1997) 1.11
Comparative nucleotide sequence analysis of two types of larval beta-globin mRNAs of Xenopus laevis. Nucleic Acids Res (1985) 1.07
Sensitive and quantitative detection of PCR-amplified HIV-1 DNA products by an enzyme linked immunoassay following solution hybridization with two differently labelled oligonucleotide probes. Mol Cell Probes (1993) 1.05
Degradation of the ribosomal genes by DNAse I in Physarum polycephalum. Eur J Biochem (1978) 0.98
Isolation of a minichromosome containing the ribosomal genes from Physarum polycephalum. Biochemistry (1979) 0.94
Isolation of human pathogenic viruses from clinical material on CaCo2 cells. J Virol Methods (1985) 0.94
Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group. Eur J Pediatr (1992) 0.92
Palliative surgical procedures to restore shoulder function in obstetric brachial palsy. Critical analysis of Narakas' series. Hand Clin (1995) 0.90
Evaluation of diagnostic tests for HIV infection in infants born to HIV-infected mothers in Switzerland. AIDS (1988) 0.90
Elective neck dissection versus observation in primary parotid carcinoma. Otolaryngol Head Neck Surg (2005) 0.89
Accessibility of the ribosomal genes to micrococcal nuclease in Physarum polycephalum. Biochim Biophys Acta (1979) 0.89
The origin of faecal fat. Gut (1969) 0.88
Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania. Acta Trop (1986) 0.87
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infect Dis (2015) 0.86
Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukaemia/lymphoma virus (HTLV) positive lymphoma. Lancet (1984) 0.85
Characterization of chick liver chromatin and analysis of its in vitro transcription products. Nucleic Acids Res (1978) 0.85
Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay. J Med Virol (1996) 0.85
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infect Dis (2014) 0.85
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infect Dis (2015) 0.84
Use of silver staining (dieterlé's stain) in the diagnosis of cat scratch disease. Histopathology (1986) 0.84
Anti-HIV IgM antibody analysis during early manifestations of HIV infections. AIDS (1987) 0.84
A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120. J Infect Dis (1994) 0.84
Quantification of in vitro retroviral replication using a one-tube real-time RT-PCR system incorporating direct RNA preparation. J Virol Methods (2001) 0.83
The primary structure of the larval beta 1-globin gene of Xenopus laevis and its flanking regions. Nucleic Acids Res (1984) 0.83
Antibodies against three purified structural proteins of the human type-C retrovirus, HTLV, in Japanese adult T-cell leukemia patients, healthy family members, and unrelated normals. Int J Cancer (1983) 0.83
Conserved sequences and cell-specific DNase I hypersensitive sites upstream from the co-ordinately expressed alpha I- and alpha II-globin genes of Xenopus laevis. J Mol Biol (1986) 0.83
High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infect Dis (2011) 0.83
Influence of breast milk on nosocomial rotavirus infections in infants. Infection (1984) 0.82
Sequence analysis of the upstream regions of Xenopus laevis beta-globin genes and arrangement of repetitive elements within the globin gene clusters. Mol Biol Rep (1990) 0.81
Primer extension analysis provides a sensitive tool for the identification of PCR-amplified DNA from HIV-1. J Virol Methods (1993) 0.81
The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression. J Virol (1998) 0.81
[Sensitive virologic evaluation in suspected meningitis: study of a radioimmunotest for the detection of IgM antibodies against ECHO 9 and ECHO 11 viruses]. Schweiz Med Wochenschr (1983) 0.81
PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology (1993) 0.81
Reaction pattern of immunoglobulin M and G antibodies to echovirus 11 structural proteins. J Clin Microbiol (1984) 0.80
Stable human immunodeficiency virus encephalopathy in two infants receiving early intravenous gammaglobulin plus antimicrobial prophylaxis. Eur J Pediatr (1989) 0.80
Chromatin structure of Physarum polycephalum plasmodia and amoebae. FEBS Lett (1978) 0.80
Human retrovirology. Facts and concepts. Curr Top Microbiol Immunol (1989) 0.80
Extraskeletal myxoid chondrosarcoma. A case report with histochemical and ultrastructural features. Appl Pathol (1983) 0.79
Defective viral RNAs in Aedes albopictus C6/36 cells persistently infected with Semliki Forest virus. Virology (1983) 0.79
A prospective evaluation of the feasibility and utility of additional tools to obtain information from recently diagnosed HIV infected patients. Swiss Med Wkly (2008) 0.79
Cross-reactions of immunoglobulin M and G antibodies with enterovirus-specific viral structural proteins. J Hyg (Lond) (1985) 0.78
Increases in Condomless Sex in the Swiss HIV Cohort Study. Open Forum Infect Dis (2015) 0.78
Evidence for HTLV-I associated with mycosis fungoides and B-cell chronic lymphocytic leukemia. Arch Dermatol (1986) 0.78
Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002. Vaccine (2004) 0.78
Effects of a 110 kilometers ultra-marathon race on plasma hormone levels. Int J Sports Med (1997) 0.77
Three-dimensional electron microscopy of entire cells. J Microsc (1990) 0.77
Biochemical evidence for a DNA repeat length in the chromatin of Dictyostelium discoideum. FEBS Lett (1977) 0.77
First documented case of human immunodeficiency virus type 2 infection in an asymptomatic Swiss subject. Eur J Clin Microbiol Infect Dis (1989) 0.76
HTLV-III: the etiologic agent of AIDS. Princess Takamatsu Symp (1984) 0.76
Immunological evaluation in the early diagnosis of prenatal or perinatal HIV infection. Arch Dis Child (1989) 0.75
Sensitivity of heat-denatured p24 antigen in the diagnosis of pediatric HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.75
Selective disappearance of two secreted host proteins in the course of Semliki Forest virus infection of Aedes albopictus cells. J Virol (1981) 0.75
[Possibilities and limits in the detection of nosocomial rotavirus infections]. Helv Paediatr Acta (1985) 0.75
[Complicated knee injuries with associated vascular lesions]. Helv Chir Acta (1985) 0.75
[Prevalence of antibodies against HTLV-III in various regions in Switzerland]. Schweiz Med Wochenschr (1985) 0.75
[Human immunodeficiency virus: virological aspects]. Schweiz Rundsch Med Prax (1986) 0.75
[HIV--virological and biological aspects and their significance for diagnosis, prevention and therapy]. Ther Umsch (1988) 0.75
[HTLV-III antibodies and risk factors for healthy homosexuals in Zurich]. Schweiz Med Wochenschr (1985) 0.75
[HIV serodiagnosis in practice]. Schweiz Rundsch Med Prax (1986) 0.75
[Retroviruses, human tumors and autoimmune diseases]. Schweiz Med Wochenschr (1986) 0.75
[A possible new prognostic criterium for acute myelocytic leukemia: speed of the titer increase of antiviral antibodies after virus oncolysate injections]. Schweiz Med Wochenschr (1979) 0.75
Vaccines and their transfection potency. Vaccine (1999) 0.75
[Acquired immunodeficiency syndrome in a child of Swiss origin whose mother died from AIDS]. Helv Paediatr Acta (1985) 0.75
Reverse transcriptase assay based on product enhancement for assessing the drug susceptibility of retroviruses. Methods Mol Med (2000) 0.75
Sequence analysis of the larval beta II-globin gene of Xenopus laevis. Mol Biol Rep (1986) 0.75
Immunophilins and HIV-1 infection. Arch Virol (2002) 0.75
Collision photography: polarization imaging of atom-molecule collisions. J Chem Phys (2004) 0.75
[Arthroscopy should not become a victim of its own success]. Rev Med Suisse Romande (1989) 0.75
[25-year-old therapy naive patient with 3 class resistant HIV infection]. Praxis (Bern 1994) (2003) 0.75
Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome. Prog Clin Biol Res (1985) 0.75
Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay. Pharmeuropa Spec Issue Biol (2002) 0.75
Prolonged seroconversion in an elite controller of HIV-1 infection. J Clin Virol (2009) 0.75
[Diagnosis of hepatitis B: is the additional demonstration of viral genome of a prognostic value?]. Schweiz Med Wochenschr (1986) 0.75
No indication for activation of exogenous retroviruses in patients with renal allograft rejection. Clin Nephrol (2006) 0.75